Cargando…
SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma
Background: Although weak SWI/SNF related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1) expression is a known diagnostic and prognostic biomarker in several malignancies, its expression and clinical significance in osteosarcoma remain unknown. The aim of the...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753343/ https://www.ncbi.nlm.nih.gov/pubmed/34984436 http://dx.doi.org/10.1042/BSR20212446 |